Larissa Lezina

1.3k total citations
20 papers, 1.0k citations indexed

About

Larissa Lezina is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Larissa Lezina has authored 20 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 10 papers in Oncology and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Larissa Lezina's work include Epigenetics and DNA Methylation (5 papers), Cancer-related Molecular Pathways (4 papers) and RNA modifications and cancer (3 papers). Larissa Lezina is often cited by papers focused on Epigenetics and DNA Methylation (5 papers), Cancer-related Molecular Pathways (4 papers) and RNA modifications and cancer (3 papers). Larissa Lezina collaborates with scholars based in United Kingdom, Russia and United States. Larissa Lezina's co-authors include Nickolai A. Barlev, Alexey V. Antonov, Paul M. Lieberman, Salvador Macip, Nick A. Barlev, Gerry Melino, Susan Giblett, Jinli Luo, C. T. Foster and Timothy W. Gant and has published in prestigious journals such as Journal of Biological Chemistry, Nano Letters and Blood.

In The Last Decade

Larissa Lezina

20 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Larissa Lezina United Kingdom 14 679 222 149 127 124 20 1.0k
Xiaoyang Zheng United States 11 472 0.7× 151 0.7× 68 0.5× 72 0.6× 72 0.6× 15 863
Takashi Furusawa United States 20 952 1.4× 156 0.7× 69 0.5× 224 1.8× 210 1.7× 41 1.4k
Md Zahidul Islam Pranjol United Kingdom 16 333 0.5× 185 0.8× 37 0.2× 126 1.0× 163 1.3× 49 878
Jia You China 17 635 0.9× 167 0.8× 32 0.2× 297 2.3× 318 2.6× 33 1.1k
Irina Perdivara United States 14 499 0.7× 78 0.4× 72 0.5× 71 0.6× 87 0.7× 18 793
Julian M. Rozenberg Russia 16 461 0.7× 134 0.6× 37 0.2× 72 0.6× 106 0.9× 34 792
Mengrou Lu United States 12 670 1.0× 137 0.6× 18 0.1× 70 0.6× 120 1.0× 23 937
Ernesto Cortés United Kingdom 15 383 0.6× 387 1.7× 70 0.5× 151 1.2× 133 1.1× 26 1.2k
Alberto Peláez‐García Spain 21 821 1.2× 326 1.5× 71 0.5× 149 1.2× 323 2.6× 44 1.3k

Countries citing papers authored by Larissa Lezina

Since Specialization
Citations

This map shows the geographic impact of Larissa Lezina's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Larissa Lezina with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Larissa Lezina more than expected).

Fields of papers citing papers by Larissa Lezina

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Larissa Lezina. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Larissa Lezina. The network helps show where Larissa Lezina may publish in the future.

Co-authorship network of co-authors of Larissa Lezina

This figure shows the co-authorship network connecting the top 25 collaborators of Larissa Lezina. A scholar is included among the top collaborators of Larissa Lezina based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Larissa Lezina. Larissa Lezina is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lezina, Larissa, et al.. (2025). CD320 Receptor and Vitamin B12 as Potential Targets for Anti-Cancer Therapy. International Journal of Molecular Sciences. 26(12). 5652–5652. 1 indexed citations
2.
Butterworth, Michael, Larissa Lezina, Lynne Howells, et al.. (2024). An optimised patient-derived explant platform for breast cancer reflects clinical responses to chemotherapy and antibody-directed therapy. Scientific Reports. 14(1). 12833–12833. 4 indexed citations
3.
Piletsky, Stanislav, Elena Piletska, Larissa Lezina, et al.. (2023). Modulation of EGFR Activity by Molecularly Imprinted Polymer Nanoparticles Targeting Intracellular Epitopes. Nano Letters. 23(21). 9677–9682. 9 indexed citations
4.
Daks, Alexandra, Oleg Shuvalov, Olga Fedorova, et al.. (2021). p53-Independent Effects of Set7/9 Lysine Methyltransferase on Metabolism of Non-Small Cell Lung Cancer Cells. Frontiers in Oncology. 11. 706668–706668. 12 indexed citations
5.
Fedorova, Olga, Alexandra Daks, Varvara Petrova, et al.. (2018). Novel isatin-derived molecules activate p53 via interference with Mdm2 to promote apoptosis. Cell Cycle. 17(15). 1917–1930. 26 indexed citations
6.
Canfarotta, Francesco, Larissa Lezina, António Guerreiro, et al.. (2018). Specific Drug Delivery to Cancer Cells with Double-Imprinted Nanoparticles against Epidermal Growth Factor Receptor. Nano Letters. 18(8). 4641–4646. 139 indexed citations
7.
Lezina, Larissa, Ruth V. Spriggs, Daniel Beck, et al.. (2018). CD40L/IL-4–stimulated CLL demonstrates variation in translational regulation of DNA damage response genes including ATM. Blood Advances. 2(15). 1869–1881. 14 indexed citations
8.
Beck, Daniel, Ruth Barber, Siân Evans, et al.. (2016). Synthetic Lethal Screen Demonstrates That a JAK2 Inhibitor Suppresses a BCL6-dependent IL10RA/JAK2/STAT3 Pathway in High Grade B-cell Lymphoma. Journal of Biological Chemistry. 291(32). 16686–16698. 12 indexed citations
9.
Rada, Miran, Е. А. Васильева, Larissa Lezina, et al.. (2016). Human EHMT2/G9a activates p53 through methylation-independent mechanism. Oncogene. 36(7). 922–932. 42 indexed citations
10.
Smallwood, Dawn T., Benedetta Apollonio, Shaun Willimott, et al.. (2016). Extracellular vesicles released by CD40/IL-4–stimulated CLL cells confer altered functional properties to CD4+ T cells. Blood. 128(4). 542–552. 47 indexed citations
11.
Lezina, Larissa, Vasilisa Aksenova, Olga Fedorova, et al.. (2015). KMT Set7/9 affects genotoxic stress response via the Mdm2 axis. Oncotarget. 6(28). 25843–25855. 50 indexed citations
12.
Lezina, Larissa, Vasilisa Aksenova, Т. А. Иванова, et al.. (2014). KMTase Set7/9 is a critical regulator of E2F1 activity upon genotoxic stress. Cell Death and Differentiation. 21(12). 1889–1899. 47 indexed citations
13.
Althubiti, Mohammad, Larissa Lezina, Rebekah Jukes‐Jones, et al.. (2014). Characterization of novel markers of senescence and their prognostic potential in cancer. Cell Death and Disease. 5(11). e1528–e1528. 209 indexed citations
14.
Lezina, Larissa, Alexey V. Antonov, Т. А. Иванова, et al.. (2013). miR-16 and miR-26a target checkpoint kinases Wee1 and Chk1 in response to p53 activation by genotoxic stress. Cell Death and Disease. 4(12). e953–e953. 67 indexed citations
15.
Fedorova, Olga, А. С. Цимоха, Tatiana N. Moiseeva, et al.. (2010). 26S proteasome exhibits endoribonuclease activity controlled by extra-cellular stimuli. Cell Cycle. 9(4). 840–849. 37 indexed citations
16.
Foster, C. T., Oliver M. Dovey, Larissa Lezina, et al.. (2010). Lysine-Specific Demethylase 1 Regulates the Embryonic Transcriptome and CoREST Stability. Molecular and Cellular Biology. 30(20). 4851–4863. 155 indexed citations
17.
Atanasiu, Constandache, Larissa Lezina, & Paul M. Lieberman. (2004). DNA Affinity Purification of Epstein-Barr Virus OriP-Binding Proteins. Humana Press eBooks. 292. 267–276. 10 indexed citations
18.
Deng, Zhong, et al.. (2002). Telomeric Proteins Regulate Episomal Maintenance of Epstein-Barr Virus Origin of Plasmid Replication. Molecular Cell. 9(3). 493–503. 104 indexed citations
19.
Lezina, Larissa, et al.. (1999). Phosphorylation of TFIIA Stimulates TATA Binding Protein-TATA Interaction and Contributes to Maximal Transcription and Viability in Yeast. Molecular and Cellular Biology. 19(4). 2846–2852. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026